FDA Investigator

Francis A Guidry

Latest inspection on record: Baton Rouge, United States, February 2020 · records back to 2008

Human DrugsFoods & CosmeticsMedical Devices & Rad HealthBiologicsAnimal Drugs & Feeds

FDA inspection record · Last updated July 12, 2026

Overview

  • 230 inspections across 212 sites are on record.
  • 305 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2020-02-14.

At a glance

Inspections

230

Sites

212

Observations

305

Career since

Jan 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Owen Biosciences Inc14 Feb 2020Human DrugsView 483 →
Exxonmobil Product Solutions Company11 Dec 2019Animal Drugs & Feeds
Chadwick Pharmaceuticals, Inc5 Dec 2019Human Drugs
FARMAKEIO OUTSOURCING LLC30 Oct 2019Human DrugsOn file
Synergy Health Ede B.v.13 Sep 2019Human Drugs

Sites inspected

Owen Biosciences IncBaton Rouge, United States1 insp.
Exxonmobil Product Solutions CompanyBaton Rouge, United States1 insp.
Chadwick Pharmaceuticals, IncMadison, United States1 insp.
FARMAKEIO OUTSOURCING LLCSouthlake, United States1 insp.
Synergy Health Ede B.v.Etten-Leur, Netherlands1 insp.

Co-investigators

Investigators who share inspections with this person.

June P Page2 shared
Melanie L Drayton2 shared
Cynthia R Gibson1 shared

Full investigator report

Get the verbatim findings behind Francis A Guidry's 305 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site